Skip to main content
. 1998 Jul 21;95(15):8847–8851. doi: 10.1073/pnas.95.15.8847

Table 1.

Summary of the β-catenin gene mutations in mouse and human hepatocarcinomas

Deletions Mouse
Human
PK/c-myc WHV/c-myc PK/H-ras Samples Cell lines§
m exon 2 (aa 12-37)* 1/30
m exon 2 (aa 19-74)* 1/30
m exon 2 (aa 5-80)* 9/30 2/20 3/11
m exons 2-4 (aa 22-172)* 1/30
m exons 2-5 (aa 32-249)* 1/11
h exons 3-4 (aa 25-140)* HepG2
h exons 3-4 (aa 20-151)* 1/26
Point mutations

D32N D32V, D32Y
S33C, S33Y S33F
G34V G34V (2), G34E G34E G34V(HuH6)
S37P S37F S37Y
T41A T41I (2)
S45P
Total mutations 17/30 10/20 4/11 6/26 2/5

The exon encoding the GSK-3β phosphorylation site is exon 2 for the mouse (m) and exon 3 for human (h). 

*

Amino acid deleted according to mRNA analysis. 

m exon 2 encodes aa 5-80 in the mouse β-catenin gene. 

Mutations detected on two independent tumors. 

§

The different cell lines tested were the HepG2, HuH6, PLC/PRF/5, Hep3B, and Huh7.